Prospective Study about Extension of Dosing Interval with Tocilizumab Therapy in Rheumatoid Arthritis Patients in Remission Maintenance

被引：0
|
作者：
Kikuchi, Jun [1 ]
Shibata, Akiko [1 ]
Sakai, Ryota [1 ]
Chino, Kentaro [1 ]
Kondo, Tsuneo [1 ]
Okuyama, Ayumi [1 ]
Takei, Hirofumi [1 ]
Amano, Koichi [1 ]
机构：
[1] Saitama Med Univ, Saitama Med Ctr, Dept Rheumatol & Clin Immunol, Saitama, Japan
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
588
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy and tolerability of six-week extended dosing interval with tocilizumab therapy in a prospective cohort as remission maintenance in patients with rheumatoid arthritis
    Kikuchi, Jun
    Kondo, Tsuneo
    Shibata, Akiko
    Sakai, Ryota
    Okada, Yusuke
    Chino, Kentaro
    Okuyama, Ayumi
    Kurasawa, Takahiko
    Takei, Hirofumi
    Amano, Koichi
    [J]. MODERN RHEUMATOLOGY, 2018, 28 (03) : 444 - 451
  • [2] Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience
    Oscar Epis
    Cinzia Casu
    Laura Belloli
    Emanuela Schito
    Davide Filippini
    Marina Muscarà
    Eleonora Bruschi
    [J]. Rheumatology International, 2015, 35 : 1569 - 1570
  • [3] Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience
    Epis, Oscar
    Casu, Cinzia
    Belloli, Laura
    Schito, Emanuela
    Filippini, Davide
    Muscara, Marina
    Bruschi, Eleonora
    [J]. RHEUMATOLOGY INTERNATIONAL, 2015, 35 (09) : 1569 - 1570
  • [4] Possibility of Extension of the Administration Interval of Tocilizumab in the Treatment of Rheumatoid Arthritis
    Sato, Masao
    Takemura, Masao
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [5] IDENTIFICATION OF SYNOVITIS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL REMISSION DURING THERAPY WITH TOCILIZUMAB
    Panasyuk, E.
    Smirnov, A.
    Fedorenko, E.
    Gavva, T.
    Gubar, E.
    Loginova, E.
    Lukina, G.
    Luchikhina, E.
    Tsvetkova, E.
    Avdeeva, A.
    Alexandrova, E.
    Nasonov, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 508 - 509
  • [6] Decrease of Tocilizumab in Rheumatoid Arthritis in Remission : A Multicenter Study
    Desbarbieux, Renaud
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [7] SAFETY OF TOCILIZUMAB THERAPY IN HBSAG CARRIERS WITH RHEUMATOID ARTHRITIS: A PROSPECTIVE STUDY
    Fang, L.
    Liao, Z.
    Lin, Z.
    Jin, O.
    Pan, Y.
    Gu, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 485 - 485
  • [8] DISCONTINUATION OF TOCILIZUMAB AFTER ATTAINING REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Nampei, A.
    Nagayama, Y.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 877 - 877
  • [9] THE INFLUENCE OF FATIGUE IN THE DEFINITION OF REMISSION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB
    Gaetano, J.
    Oliveira, S.
    Delgado Alves, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1131 - 1132
  • [10] TOCILIZUMAB INDUCE REMISSION FROM THE FIRST INFUSION IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Becerra, F.
    Garcia, E.
    Terrazas, H.
    Rhor, F.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S31 - S31
12345